Also found in: Dictionary, Wikipedia.
Related to glimepiride: metformin


a sulfonylurea compound used as a hypoglycemic in treatment of type 2 diabetes mellitus; administered orally.


Amaryl, Apo-Glimepiride (CA), CO Glimepiride (CA), Novo-Glimepiride (CA), PMS-Glimepiride (CA), Ratio-Glimepiride (CA), Sandoz Glimepiride (CA)

Pharmacologic class: Sulfonylurea

Therapeutic class: Hypoglycemic

Pregnancy risk category C


Lowers blood glucose level by stimulating insulin release from pancreas, increasing insulin sensitivity at receptor sites, and decreasing hepatic glucose production. Also increases peripheral tissue sensitivity to insulin and causes mild diuresis.


Tablets: 1 mg, 2 mg, 4 mg

Indications and dosages

Adjunct to diet and exercise to lower blood glucose level in type 2 (non-insulin-dependent) diabetes mellitus

Adults: Initially, 1 to 2 mg P.O. daily given with first main meal; usual maintenance dosage is 1 to 4 mg P.O. daily. When patient reaches 2 mg/day, increase no more than 2 mg q 1 to 2 weeks, depending on glycemic control. Maximum dosage is 8 mg/day.

Dosage adjustment

• Renal or hepatic impairment
• Adrenal or pituitary insufficiency


• Hypersensitivity to drug
• Diabetic coma or ketoacidosis
• Severe renal, hepatic, or endocrine disease
• Pregnancy or breastfeeding


Use cautiously in:
• mild to moderate hepatic or renal disease; cardiovascular disease; impaired thyroid, pituitary, or adrenal function
• elderly patients.


• Check baseline creatinine level for normal renal function before giving first dose.
• Give with first meal of day.

Adverse reactions

CNS: dizziness, drowsiness, headache, weakness

CV: increased CV mortality risk

EENT: blurred vision

GI: nausea, vomiting, diarrhea, constipation, cramps, heartburn, epigastric distress, anorexia

Hematologic: aplastic anemia, leukopenia, pancytopenia, thrombocytopenia, agranulocytosis

Hepatic: cholestatic jaundice, hepatitis

Metabolic: hyponatremia, hypoglycemia

Skin: rash, erythema, maculopapular eruptions, urticaria, eczema, angioedema, photosensitivity

Other: increased appetite


Drug-drug.Androgens (such as testosterone), chloramphenicol, clofibrate, guanethidine, MAO inhibitors, nonsteroidal anti-inflammatory drugs (except diclofenac), salicylates, sulfonamides, tricyclic antidepressants: increased risk of hypoglycemia

Beta-adrenergic blockers: altered response to glimepiride, necessitating dosage change; prolonged hypoglycemia (with nonselective agents)

Calcium channel blockers, corticosteroids, estrogens, hydantoins, hormonal contraceptives, isoniazid, nicotinic acid, phenothiazines, phenytoin, rifampin, sympathomimetics, thiazide diuretics, thyroid preparations: decreased hypoglycemic effect of glimepiride

Warfarin: initially increased, then decreased, effects of both drugs

Drug-diagnostic tests.Alanine aminotransferase, alkaline phosphatase, aspartate aminotransferase, bilirubin, blood urea nitrogen, cholesterol, liver function tests: increased values

Glucose, granulocytes, hemoglobin, platelets, white blood cells: decreased values

Drug-herbs.Agoral marshmallow, aloe (oral), bitter melon, burdock, chromium, coenzyme Q10, dandelion, eucalyptus, fenugreek: additive hypoglycemic effects

Glucosamine: impaired glycemic control

Drug-behaviors.Alcohol use: disulfiram-like reaction

Sun exposure: increased risk of photosensitivity

Patient monitoring

• Monitor CBC with white cell differential, electrolyte levels, and blood chemistry results.
• Monitor blood glucose level regularly. Assess glycosylated hemoglobin level every 3 to 6 months.
• Evaluate kidney and liver function test results frequently, especially in patients with impairments.
• Assess neurologic status. Report cognitive or sensory impairment.

Patient teaching

• Instruct patient to self-monitor his blood glucose level as prescribed.
• Teach patient how to recognize signs and symptoms of hypoglycemia and hyperglycemia.
• Stress importance of diet and exercise to help control diabetes.
• Instruct patient to wear or carry medical identification describing his condition.
• Advise patient to keep sugar source readily available at all times in case of hypoglycemia.
• Caution patient to avoid driving and other hazardous activities until he knows how drug affects concentration and alertness.
• Tell patient he will undergo regular blood testing during therapy.
• As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the drugs, tests, herbs, and behaviors mentioned above.


/gli·mep·i·ride/ (gli-mep´ĭ-rīd) a sulfonylurea compound used as a hypoglycemic in the treatment of type 2 diabetes mellitus.


A sulfonylurea drug, C24H34N4O5S, used to treat type 2 diabetes.


a sulfonylurea compound used as a hypoglycemic in treatment of type 2 diabetes mellitus, administered orally.


An agent which may be used in combination with metformin (Glucophage) as 2nd-line therapy for type-2 diabetes when monotherapy with either Amaryl or metformin fail to achieve adequate blood glucose control.


Amaryl® Endocrinology An oral hypoglycemic sulfonurea used in type 2 DM, if hyperglycemia does not respond to diet and exercise Side effects Vertigo, asthenia, nausea, hypoglycemia


A SULPHONYLUREA drug used to treat maturity onset (Type II) DIABETES. A brand name is Amaryl.

glimepiride (glimep´ərīd),

n brand name: Amaryl;
drug class: oral antidiabetic;
action: a sulfonylurea type action;
use: non insulin-dependent diabetes, sometimes in combination with insulin support.
References in periodicals archive ?
Currently, glimepiride is the best-selling product of sulfonylurea in the Chinese market.
and Eli Lilly and Company (NYSE: LLY) today announced the clinical trial enrollment of patients for CAROLINA (Cardiovascular Outcome Study of Linagliptin versus Glimepiride in Patients with Type 2 Diabetes) has been completed.
Additionally, among diabetes patients with heart disease, only glimepiride did not increase the risk of death compared to metformin.
The sulfonylureas were kindly supplied by the following manufacturers: glibenclamide, glimepiride, and tolbutamide by Aventis (Paris, France); glipizide and chlorpropamide by Pfizer (Paris, France); gliclazide and carbutamide by Servier (Neuilly-sur-Seine, France); glibornuride by CSP (Cournon, France); and glisoxepide by Bayer (Puteaux, France).
Amaryl is the trade name for glimepiride, which is approved for treating type 2 diabetes and is marketed by Aventis.
Glimepiride may increase peripheral tissue insulin sensitivity.
WOSULIN R/Human Actrapid), Glucose Estimation Strip (BOT Of 50 Strip) Or Equivalent, Lancet, Battery For Glucometer, Metformin 500mg Sr Tab, Glimepiride 2mg Tab, Cap Isotretinoin 200mg.
And glibenclamide, gliquidone, glipizide and glimepiride are the common drugs in the class of sulfonylurea.
The drugs that will become cheaper would include atorvastatin, gliclazide, glimepiride, heparin and metolazone among others.
C'est le cas par exemple du prix du Glimepiride (AMAREL 4 mg Comprime BoEte de 30), traitement largement utilise dans le traitement du diabete sucre non insulinodependant (de type 2), est passe de 180 DH a 84 DH comme nouveau prix de vente Il s'agit en outre des antibiotiques qui sont des anti-infectieux generaux a usage systemique, tels que l'Ofloxacine (OFLOCET 200 mg Comprime pellicule secable Boite de 10), medicament prescrit dans le traitement des infections bacteriennes, son prix est passe de 208,65 DH a 109,60 DH comme nouveau prix de vente.
Michael Nauck, a German diabetes expert, who cited the good safety and efficacy performance of sulfonylureas in big trials such as the UKPDS, and said that a decision on the drug class will need to wait until data are available from the CAROLINA trial, which is comparing the sulfonylurea glimepiride and the DPP4 inhibitor linagliptin in about 6,000 patients at more than 600 worldwide centers.
After 104 weeks of treatment, both linagliptin and glimepiride reduced mean A1C levels by 0.